172 related articles for article (PubMed ID: 12799281)
21. [Telomeres and telomerase in leukemias].
Werda L; Skotnicki AB
Przegl Lek; 1999; 56(10):668-70. PubMed ID: 10695383
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.
Wang JC; Warner JK; Erdmann N; Lansdorp PM; Harrington L; Dick JE
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14398-403. PubMed ID: 16172394
[TBL] [Abstract][Full Text] [Related]
23. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
24. Telomere length homeostasis.
Hug N; Lingner J
Chromosoma; 2006 Dec; 115(6):413-25. PubMed ID: 16741708
[TBL] [Abstract][Full Text] [Related]
25. Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes.
Aubert G; Baerlocher GM; Vulto I; Poon SS; Lansdorp PM
PLoS Genet; 2012; 8(5):e1002696. PubMed ID: 22661914
[TBL] [Abstract][Full Text] [Related]
26. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells.
Allsopp RC; Cheshier S; Weissman IL
J Exp Med; 2001 Apr; 193(8):917-24. PubMed ID: 11304552
[TBL] [Abstract][Full Text] [Related]
27. Telomeres and telomerase in human leukemias.
Shay JW; Werbin H; Wright WE
Leukemia; 1996 Aug; 10(8):1255-61. PubMed ID: 8709628
[TBL] [Abstract][Full Text] [Related]
28. Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?
Awaya N; Baerlocher GM; Manley TJ; Sanders JE; Mielcarek M; Torok-Storb B; Lansdorp PM
Biol Blood Marrow Transplant; 2002; 8(11):597-600. PubMed ID: 12463478
[TBL] [Abstract][Full Text] [Related]
29. Telomere and telomerase in stem cells.
Hiyama E; Hiyama K
Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
[TBL] [Abstract][Full Text] [Related]
30. The role of telomerase expression and telomere length maintenance in human and mouse.
Weng NP; Hodes RJ
J Clin Immunol; 2000 Jul; 20(4):257-67. PubMed ID: 10939713
[TBL] [Abstract][Full Text] [Related]
31. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
32. Hematopoiesis under telomere attrition at the single-cell resolution.
Thongon N; Ma F; Santoni A; Marchesini M; Fiorini E; Rose A; Adema V; Ganan-Gomez I; Groarke EM; Gutierrez-Rodrigues F; Chen S; Lockyer P; Schneider S; Bueso-Ramos C; Montalban-Bravo G; Class CA; Soltysiak KA; Pellegrini M; Sahin E; Bertuch AA; DiNardo CD; Garcia-Manero G; Young NS; Dwyer K; Colla S
Nat Commun; 2021 Nov; 12(1):6850. PubMed ID: 34824242
[TBL] [Abstract][Full Text] [Related]
33. Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Brummendorf TH; Ersoz I; Hartmann U; Balabanov S; Wolke H; Paschka P; Lahaye T; Berner B; Bartolovic K; Kreil S; Berger U; Gschaidmeier H; Bokemeyer C; Hehlmann R; Dietz K; Lansdorp PM; Kanz L; Hochhaus A
Ann N Y Acad Sci; 2003 May; 996():26-38. PubMed ID: 12799279
[TBL] [Abstract][Full Text] [Related]
34. Telomere biology in hematopoiesis and stem cell transplantation.
Gadalla SM; Savage SA
Blood Rev; 2011 Nov; 25(6):261-9. PubMed ID: 21764192
[TBL] [Abstract][Full Text] [Related]
35. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
[TBL] [Abstract][Full Text] [Related]
36. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
37. [Regulation of senescence by telomeres and telomerase].
Hayashi MT
Nihon Rinsho; 2016 Sep; 74(9):1485-1490. PubMed ID: 30557481
[TBL] [Abstract][Full Text] [Related]
38. Telomeres and telomerase in hematologic neoplasia.
Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
[TBL] [Abstract][Full Text] [Related]
39. Elderly human hematopoietic progenitor cells express cellular senescence markers and are more susceptible to pyroptosis.
Fali T; Fabre-Mersseman V; Yamamoto T; Bayard C; Papagno L; Fastenackels S; Zoorab R; Koup RA; Boddaert J; Sauce D; Appay V
JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997288
[TBL] [Abstract][Full Text] [Related]
40. Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.
Yu W; Qin X; Jin Y; Li Y; Santiskulvong C; Vu V; Zeng G; Zhang Z; Chow M; Rao J
Oncotarget; 2017 Jan; 8(5):7977-7988. PubMed ID: 28002788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
